NASDAQ NMS - GLOBAL MARKET · BBNX
0.00% · $0.0000 · Vol Not reported
Market closed · last close shown
Beta Bionics Inc

Beta Bionics Inc

Health Care
$18.08
Card
Relationship Map

Follow $BBNX

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $BBNX by email

Veridion Score

BETALOW CONF · 6 of 6 factors measuredMethodology
BBNX
Beta Bionics Inc
Wed Oct 7 · last completed session · Pre-market · regular session opens 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
Middle range · LOW confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 6 of 6 factors measured · Wed Oct 7 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is BBNX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading BBNX catalysts
About Beta Bionics Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
2025
Employees
423
Country
US

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$18.08
Last session
Day high
$18.08
Last session
Day low
$18.08
Last session
Previous close
$18.08
52W high
$31.99
-43.48% from high
52W low
$8.86
40% of range
Market cap
$975.3M
EPS
$-1.6481
Beta
0.83
Shares out
53.9M
Avg volume
1.3M
VWAP
$18.08
Last session
Price history computed in-house
1W
-4.19%
1M
-6.47%
3M
+6.17%
1Y
-18.30%
YTD
-40.66%
SMA 50 $18.52 · below
SMA 200 $15.66 · above
52W position 40%

BBNX overview

Veridion Score
59
Registered · 2026-10-07
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around BBNX.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading BBNX Form 4 filings
Public disclosures

Congress activity in BBNX

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

BBNX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BBNX in this window.
Lobbying spend

BBNX lobbying filings, year to date.

Registered lobbying filings matched to Beta Bionics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BBNX in this window.
Loading news for BBNX
Analyst ratings
Sovereign unlock shows live analyst consensus for BBNX.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.